Keith R. Martin

Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial

David F. Garway‐Heath, David P. Crabb, Catey Bunce et al. · The Lancet · 2014 · 657 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +14

Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signaling versus high-dose toxicity

Keith R. Martin, J. Carl Barrett · Human & Experimental Toxicology · 2002 · 365 citations · Full text

Life Sciences, Cell Biology, Apoptosis +16

A Twenty-Year Follow-up Study of Trabeculectomy: Risk Factors and Outcomes

John Landers, Keith R. Martin, N Sarkies et al. · Ophthalmology · 2011 · 365 citations

Medicine, Surgery, Ophthalmic Surgery +11

Gene Therapy with Brain-Derived Neurotrophic Factor As a Protection: Retinal Ganglion Cells in a Rat Glaucoma Model

Keith R. Martin, Harry A. Quigley, Donald J. Zack et al. · Investigative Ophthalmology & Visual Science · 2003 · 363 citations

Medicine, Ophthalmology, Vision Science +16

Neuroprotective Effects of Intravitreal Mesenchymal Stem Cell Transplantation in Experimental Glaucoma

Thomas V. Johnson, Natalie D. Bull, David Hunt et al. · Investigative Ophthalmology & Visual Science · 2010 · 341 citations · Full text

Medicine, Neuroscience, Ophthalmology +15